Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jul, 2017 | Pages:
98 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017, provides an overview of the Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline landscape. Chemotherapy induced nausea and vomiting or CINV is nausea and vomiting that results specifically from treatment with chemotherapy drugs. Symptoms include a rapid heart rate, sweating, dizziness and increased saliva. Risk factors include age, drug, dose, schedule of administration and route. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 1, 2, 6, 3, 1, 11, 3 and 3 respectively. Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Chemotherapy Induced Nausea and Vomiting (Toxicology). - The pipeline guide reviews pipeline therapeutics for Chemotherapy Induced Nausea and Vomiting (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Chemotherapy Induced Nausea and Vomiting (Toxicology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Chemotherapy Induced Nausea and Vomiting (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Chemotherapy Induced Nausea and Vomiting (Toxicology) Reasons To Buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Chemotherapy Induced Nausea and Vomiting (Toxicology). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Chemotherapy Induced Nausea and Vomiting - Overview 6 Chemotherapy Induced Nausea and Vomiting - Therapeutics Development 7 Pipeline Overview 7 Pipeline by Companies 8 Products under Development by Companies 11 Chemotherapy Induced Nausea and Vomiting - Therapeutics Assessment 13 Assessment by Target 13 Assessment by Mechanism of Action 15 Assessment by Route of Administration 17 Assessment by Molecule Type 19 Chemotherapy Induced Nausea and Vomiting - Companies Involved in Therapeutics Development 20 Acacia Pharma Ltd 20 Aphios Corp 20 Astellas Pharma Inc 21 Athenex Inc 21 Camurus AB 22 Daewoong Pharmaceutical Co Ltd 22 Heron Therapeutics Inc 23 Insys Therapeutics Inc 23 Kyowa Hakko Kirin Co Ltd 24 MannKind Corp 24 Medlab Clinical Ltd 25 N4 Pharma Plc 25 Nanoform Cardiovascular Therapeutics Ltd 26 Nemus Bioscience Inc 26 RedHill Biopharma Ltd 27 Serina Therapeutics Inc 27 SoluBest Ltd 28 Suda Ltd 28 Tesaro Inc 29 Therapix Biosciences Ltd 29 Chemotherapy Induced Nausea and Vomiting - Drug Profiles 30 (netupitant + palonosetron hydrochloride) - Drug Profile 30 (palonosetron hydrochloride + Pro-netupitant) - Drug Profile 34 APD-403 - Drug Profile 35 aprepitant - Drug Profile 37 aprepitant - Drug Profile 38 aprepitant - Drug Profile 39 aprepitant - Drug Profile 40 aprepitant - Drug Profile 41 aprepitant - Drug Profile 42 Cannabis CINV - Drug Profile 43 dexamethasone - Drug Profile 44 dronabinol - Drug Profile 45 dronabinol - Drug Profile 46 FK-886 - Drug Profile 47 fosnetupitant - Drug Profile 49 granisetron hydrochloride - Drug Profile 50 granisetron hydrochloride - Drug Profile 51 granisetron hydrochloride - Drug Profile 52 granisetron hydrochloride ER - Drug Profile 53 LPI-1504 - Drug Profile 55 LPI-1505 - Drug Profile 56 NB-1222 - Drug Profile 57 NB-2111 - Drug Profile 58 netupitant - Drug Profile 59 ondansetron hydrochloride - Drug Profile 60 ondansetron hydrochloride - Drug Profile 62 ondansetron hydrochloride - Drug Profile 63 ondansetron hydrochloride - Drug Profile 64 ondansetron hydrochloride CR - Drug Profile 65 palmidrol - Drug Profile 72 palonosetron hydrochloride - Drug Profile 73 rolapitant hydrochloride - Drug Profile 74 SER-232 - Drug Profile 80 Zindol - Drug Profile 81 Chemotherapy Induced Nausea and Vomiting - Dormant Projects 82 Chemotherapy Induced Nausea and Vomiting - Discontinued Products 83 Chemotherapy Induced Nausea and Vomiting - Product Development Milestones 84 Featured News & Press Releases 84 Appendix 94 Methodology 94 Coverage 94 Secondary Research 94 Primary Research 94 Expert Panel Validation 94 Contact Us 94 Disclaimer 95
List of Tables
Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Products under Development by Companies, H2 2017 Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Number of Products by Stage and Target, H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 Number of Products by Stage and Route of Administration, H2 2017 Number of Products by Stage and Molecule Type, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Acacia Pharma Ltd, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Aphios Corp, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Astellas Pharma Inc, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Athenex Inc, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Camurus AB, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Daewoong Pharmaceutical Co Ltd, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Heron Therapeutics Inc, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Insys Therapeutics Inc, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Kyowa Hakko Kirin Co Ltd, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by MannKind Corp, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Medlab Clinical Ltd, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by N4 Pharma Plc, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Nanoform Cardiovascular Therapeutics Ltd, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Nemus Bioscience Inc, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by RedHill Biopharma Ltd, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Serina Therapeutics Inc, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by SoluBest Ltd, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Suda Ltd, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Tesaro Inc, H2 2017 Chemotherapy Induced Nausea and Vomiting - Pipeline by Therapix Biosciences Ltd, H2 2017 Chemotherapy Induced Nausea and Vomiting - Dormant Projects, H2 2017 Chemotherapy Induced Nausea and Vomiting - Discontinued Products, H2 2017
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
